| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See "remarks"
1 company
Hughes Eric A serves as a See "remarks" at TEVA. Across recent SEC filings that breaks down to 0 buys and 14 sells.
Historically, Hughes Eric A's trades have earned a below-average insider score of 31/100 across 8 rated trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -62.3%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | TEVA Teva Pharmaceutical Industries Limited | See "remarks" | Sale+OE10b5-1 | 25,578 | $34.88 | $892,050.65 | -15.9% | - | - | |
| Mar 5, 2026 | TEVA Teva Pharmaceutical Industries Limited | See "remarks" | Sale+OE10b5-1 | 9,533 | $31.67 | $301,894.86 | -8.1% | +3.4% | - | |
| Mar 4, 2026 | TEVA Teva Pharmaceutical Industries Limited | See "remarks" | Sale+OE10b5-1 | 11,277 | $32.46 | $366,102.17 | -10.4% | +0.5% | - | |
| Mar 3, 2026 | TEVA Teva Pharmaceutical Industries Limited | See "remarks" | Sale+OE10b5-1 | 80,762 | $32.36 | $2,613,450.24 | -48.5% | +7.3% | - | |
| Aug 1, 2025 | TEVA Teva Pharmaceutical Industries Ltd | See "remarks" | Sale+OE10b5-1 | 52,742 | $15.16 | $799,436.87 | - | +30.2% | +127.6% | |
| Mar 5, 2025 | TEVA Teva Pharmaceutical Industries Ltd | See "remarks" | Sale+OE10b5-1 | 23,251 | $15.80 | $367,287.74 | - | +8.1% | +99.7% | |
| Mar 4, 2025 | TEVA Teva Pharmaceutical Industries Ltd | See "remarks" | Sale+OE10b5-1 | 24,900 | $16.06 | $399,770.20 | - | +10.0% | +109.8% | |
| Aug 9, 2024 | TEVA Teva Pharmaceutical Industries Ltd | See "remarks" | Sell | 45,060 | $17.38 | $782,971.57 | -100% | +0.4% | -6.1% | |
| Aug 1, 2024 | TEVA Teva Pharmaceutical Industries Ltd | See "remarks" | Sale+OE10b5-1 | 24,537 | $17.25 | $423,280.43 | -35.3% | +6.0% | -12.3% | |
| Mar 4, 2024 | TEVA Teva Pharmaceutical Industries Ltd | See "remarks" | Sale+OE10b5-1 | 8,045 | $13.34 | $107,298.58 | -32.3% | +26.3% | +16.7% |